nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ABCB1—colon cancer	0.799	1	CbGaD
Ergotamine—CYP1A2—Fluorouracil—colon cancer	0.0106	0.237	CbGbCtD
Ergotamine—ABCB1—Irinotecan—colon cancer	0.00969	0.216	CbGbCtD
Ergotamine—Ischaemia—Irinotecan—colon cancer	0.00866	0.0913	CcSEcCtD
Ergotamine—HTR2A—myenteric nerve plexus—colon cancer	0.00859	0.154	CbGeAlD
Ergotamine—ABCB1—Vincristine—colon cancer	0.00847	0.189	CbGbCtD
Ergotamine—Localised oedema—Capecitabine—colon cancer	0.00837	0.0882	CcSEcCtD
Ergotamine—Paresthesia of limbs—Methotrexate—colon cancer	0.00821	0.0866	CcSEcCtD
Ergotamine—Emotional distress—Fluorouracil—colon cancer	0.00712	0.075	CcSEcCtD
Ergotamine—CYP3A4—Irinotecan—colon cancer	0.00581	0.13	CbGbCtD
Ergotamine—HTR2A—vein—colon cancer	0.00554	0.0989	CbGeAlD
Ergotamine—ABCB1—Methotrexate—colon cancer	0.00513	0.114	CbGbCtD
Ergotamine—CYP3A4—Vincristine—colon cancer	0.00508	0.113	CbGbCtD
Ergotamine—Peripheral coldness—Capecitabine—colon cancer	0.00444	0.0468	CcSEcCtD
Ergotamine—Numbness—Vincristine—colon cancer	0.00391	0.0413	CcSEcCtD
Ergotamine—Sensory loss—Vincristine—colon cancer	0.00374	0.0395	CcSEcCtD
Ergotamine—HTR1B—blood vessel—colon cancer	0.00365	0.0653	CbGeAlD
Ergotamine—Numbness—Fluorouracil—colon cancer	0.00365	0.0385	CcSEcCtD
Ergotamine—HTR1D—blood vessel—colon cancer	0.00354	0.0632	CbGeAlD
Ergotamine—Sensory loss—Fluorouracil—colon cancer	0.00349	0.0368	CcSEcCtD
Ergotamine—Dihydroergotamine—ABCB1—colon cancer	0.00232	0.415	CrCbGaD
Ergotamine—ADRA1D—epithelium—colon cancer	0.0023	0.0411	CbGeAlD
Ergotamine—Cyanosis—Methotrexate—colon cancer	0.00222	0.0234	CcSEcCtD
Ergotamine—ADRA1B—renal system—colon cancer	0.00218	0.039	CbGeAlD
Ergotamine—Ergonovine—ABCB1—colon cancer	0.00212	0.379	CrCbGaD
Ergotamine—HTR2A—endothelium—colon cancer	0.0019	0.034	CbGeAlD
Ergotamine—HTR2A—blood vessel—colon cancer	0.00176	0.0314	CbGeAlD
Ergotamine—Hypoaesthesia—Vincristine—colon cancer	0.00162	0.0171	CcSEcCtD
Ergotamine—Bradycardia—Irinotecan—colon cancer	0.00161	0.017	CcSEcCtD
Ergotamine—HTR2B—smooth muscle tissue—colon cancer	0.00154	0.0276	CbGeAlD
Ergotamine—Hypoaesthesia—Fluorouracil—colon cancer	0.00151	0.0159	CcSEcCtD
Ergotamine—HTR1A—renal system—colon cancer	0.00133	0.0238	CbGeAlD
Ergotamine—ADRA1A—epithelium—colon cancer	0.00132	0.0236	CbGeAlD
Ergotamine—Vertigo—Vincristine—colon cancer	0.00127	0.0134	CcSEcCtD
Ergotamine—Vertigo—Irinotecan—colon cancer	0.00124	0.0131	CcSEcCtD
Ergotamine—ADRA1A—renal system—colon cancer	0.00123	0.0219	CbGeAlD
Ergotamine—Hypertension—Vincristine—colon cancer	0.00122	0.0129	CcSEcCtD
Ergotamine—HTR2B—digestive system—colon cancer	0.00122	0.0218	CbGeAlD
Ergotamine—Myalgia—Vincristine—colon cancer	0.00121	0.0127	CcSEcCtD
Ergotamine—Hypertension—Irinotecan—colon cancer	0.00119	0.0126	CcSEcCtD
Ergotamine—Bromocriptine—ABCB1—colon cancer	0.00115	0.206	CrCbGaD
Ergotamine—ABCB1—blood vessel—colon cancer	0.00115	0.0206	CbGeAlD
Ergotamine—Myalgia—Fluorouracil—colon cancer	0.00113	0.0119	CcSEcCtD
Ergotamine—Bradycardia—Capecitabine—colon cancer	0.00108	0.0114	CcSEcCtD
Ergotamine—HTR2B—vagina—colon cancer	0.00108	0.0192	CbGeAlD
Ergotamine—Hypoaesthesia—Capecitabine—colon cancer	0.00106	0.0111	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00105	0.0111	CcSEcCtD
Ergotamine—Tachycardia—Fluorouracil—colon cancer	0.00105	0.0111	CcSEcCtD
Ergotamine—HTR2A—embryo—colon cancer	0.00105	0.0187	CbGeAlD
Ergotamine—Paraesthesia—Vincristine—colon cancer	0.00104	0.011	CcSEcCtD
Ergotamine—ADRA1A—lymphoid tissue—colon cancer	0.00102	0.0182	CbGeAlD
Ergotamine—CYP1A2—renal system—colon cancer	0.00101	0.0181	CbGeAlD
Ergotamine—Paraesthesia—Irinotecan—colon cancer	0.00101	0.0107	CcSEcCtD
Ergotamine—Pain—Vincristine—colon cancer	0.000989	0.0104	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000983	0.0104	CcSEcCtD
Ergotamine—Paraesthesia—Fluorouracil—colon cancer	0.000969	0.0102	CcSEcCtD
Ergotamine—Pain—Irinotecan—colon cancer	0.000964	0.0102	CcSEcCtD
Ergotamine—Pain—Fluorouracil—colon cancer	0.000923	0.00973	CcSEcCtD
Ergotamine—HTR2A—epithelium—colon cancer	0.000855	0.0153	CbGeAlD
Ergotamine—CYP1A2—digestive system—colon cancer	0.000832	0.0149	CbGeAlD
Ergotamine—Vertigo—Capecitabine—colon cancer	0.00083	0.00875	CcSEcCtD
Ergotamine—Asthenia—Vincristine—colon cancer	0.00083	0.00875	CcSEcCtD
Ergotamine—HTR2A—smooth muscle tissue—colon cancer	0.000824	0.0147	CbGeAlD
Ergotamine—Asthenia—Irinotecan—colon cancer	0.000808	0.00853	CcSEcCtD
Ergotamine—Hypertension—Capecitabine—colon cancer	0.000798	0.00841	CcSEcCtD
Ergotamine—HTR2A—renal system—colon cancer	0.000793	0.0142	CbGeAlD
Ergotamine—Myalgia—Capecitabine—colon cancer	0.000787	0.0083	CcSEcCtD
Ergotamine—Pruritus—Fluorouracil—colon cancer	0.000764	0.00805	CcSEcCtD
Ergotamine—ADRA1A—liver—colon cancer	0.00075	0.0134	CbGeAlD
Ergotamine—Tachycardia—Capecitabine—colon cancer	0.000736	0.00776	CcSEcCtD
Ergotamine—Vomiting—Vincristine—colon cancer	0.000736	0.00776	CcSEcCtD
Ergotamine—CYP3A4—renal system—colon cancer	0.000734	0.0131	CbGeAlD
Ergotamine—Vomiting—Irinotecan—colon cancer	0.000716	0.00755	CcSEcCtD
Ergotamine—HTR2B—lymph node—colon cancer	0.000696	0.0124	CbGeAlD
Ergotamine—Nausea—Vincristine—colon cancer	0.000687	0.00725	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000687	0.00725	CcSEcCtD
Ergotamine—ABCB1—embryo—colon cancer	0.000687	0.0123	CbGeAlD
Ergotamine—Vomiting—Fluorouracil—colon cancer	0.000686	0.00724	CcSEcCtD
Ergotamine—Paraesthesia—Capecitabine—colon cancer	0.000677	0.00714	CcSEcCtD
Ergotamine—ADRA2A—vagina—colon cancer	0.000676	0.0121	CbGeAlD
Ergotamine—Nausea—Irinotecan—colon cancer	0.000669	0.00706	CcSEcCtD
Ergotamine—HTR2A—digestive system—colon cancer	0.00065	0.0116	CbGeAlD
Ergotamine—Pain—Capecitabine—colon cancer	0.000645	0.0068	CcSEcCtD
Ergotamine—Nausea—Fluorouracil—colon cancer	0.000641	0.00676	CcSEcCtD
Ergotamine—CYP1A2—liver—colon cancer	0.00062	0.0111	CbGeAlD
Ergotamine—SLC6A2—lymph node—colon cancer	0.000618	0.011	CbGeAlD
Ergotamine—Vertigo—Methotrexate—colon cancer	0.000618	0.00652	CcSEcCtD
Ergotamine—CYP3A4—digestive system—colon cancer	0.000602	0.0108	CbGeAlD
Ergotamine—Myalgia—Methotrexate—colon cancer	0.000586	0.00618	CcSEcCtD
Ergotamine—HTR2A—vagina—colon cancer	0.000574	0.0103	CbGeAlD
Ergotamine—ABCB1—epithelium—colon cancer	0.00056	0.01	CbGeAlD
Ergotamine—Asthenia—Capecitabine—colon cancer	0.000541	0.00571	CcSEcCtD
Ergotamine—Pruritus—Capecitabine—colon cancer	0.000534	0.00563	CcSEcCtD
Ergotamine—ABCB1—renal system—colon cancer	0.00052	0.00929	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000512	0.00539	CcSEcCtD
Ergotamine—Paraesthesia—Methotrexate—colon cancer	0.000504	0.00532	CcSEcCtD
Ergotamine—HTR2A—liver—colon cancer	0.000485	0.00866	CbGeAlD
Ergotamine—Pain—Methotrexate—colon cancer	0.00048	0.00506	CcSEcCtD
Ergotamine—Vomiting—Capecitabine—colon cancer	0.00048	0.00506	CcSEcCtD
Ergotamine—CYP3A4—liver—colon cancer	0.000449	0.00802	CbGeAlD
Ergotamine—Nausea—Capecitabine—colon cancer	0.000448	0.00472	CcSEcCtD
Ergotamine—ADRA2A—lymph node—colon cancer	0.000437	0.00781	CbGeAlD
Ergotamine—ABCB1—lymphoid tissue—colon cancer	0.000432	0.00771	CbGeAlD
Ergotamine—ABCB1—digestive system—colon cancer	0.000426	0.00762	CbGeAlD
Ergotamine—Asthenia—Methotrexate—colon cancer	0.000403	0.00425	CcSEcCtD
Ergotamine—Pruritus—Methotrexate—colon cancer	0.000397	0.00419	CcSEcCtD
Ergotamine—ABCB1—bone marrow—colon cancer	0.000393	0.00702	CbGeAlD
Ergotamine—ABCB1—vagina—colon cancer	0.000376	0.00673	CbGeAlD
Ergotamine—Vomiting—Methotrexate—colon cancer	0.000357	0.00376	CcSEcCtD
Ergotamine—Nausea—Methotrexate—colon cancer	0.000333	0.00352	CcSEcCtD
Ergotamine—ABCB1—liver—colon cancer	0.000318	0.00567	CbGeAlD
Ergotamine—ABCB1—lymph node—colon cancer	0.000243	0.00435	CbGeAlD
